Myriad Genetics Inc

MYGN

Exchange: Nasdaq
Industry: In Vitro & In Vivo Diagnostic Substances
SEC CIK: 0000899923

SEC filings (opens in a new tab)

No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Myriad Genetics Inc changed between Q3 2022 and Q4 2022.

All holders in Q4 2022 All holders in Q3 2022

13F holders of MYGN: Q3 2022 compared with Q4 2022
Measure	Q3 2022	Of which not filed for Q4 2022	Q4 2022	Change
Holders	191	3	196	+8
Shares	81.5M	652	80.6M	−844.0K (−1.0%)
Value	$1.55B	$12.3K	$1.17B	−$384.9M (−24.8%)

3 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Myriad Genetics Inc at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to MYGN in Q4 2022
Institution	Shares	Value	% of portfolio
Landscape Capital Management, L.L.C.	152,773	$2.22M	0.33%
Marshall Wace, LLP	147,004	$2.13M	0.01%
Luminus Management LLC	122,691	$1.78M	0.44%
Duality Advisers, LP	52,843	$766.8K	0.09%
Jump Financial, LLC	46,029	$667.9K	0.04%
Y-Intercept (Hong Kong) Ltd	40,706	$590.6K	0.09%
HRT Financial LP	37,393	$542.0K	0.01%
Citadel Advisors LLC	33,197	$481.7K	0.00%
Maryland State Retirement & Pension System	33,161	$481.2K	0.01%
Two Sigma Investments, LP	26,740	$388.0K	0.00%
Dynamic Technology Lab Private Ltd	21,139	$307.0K	0.03%
Trexquant Investment LP	18,958	$275.1K	0.01%
Ergoteles LLC	16,583	$240.6K	0.01%
Beverly Hills Private Wealth, LLC	15,605	$226.4K	0.10%
Kula Investments, LLC	13,577	$197.0K	0.07%
ExodusPoint Capital Management, LP	12,300	$178.0K	0.00%
Hudson Bay Capital Management LP	11,284	$163.7K	0.00%
Connor, Clark & Lunn Investment Management Ltd.	11,035	$160.1K	0.00%
Point72 Middle East FZE	5,636	$81.8K	0.01%
Boston Partners	37,838	$64.4K	0.00%
Natixis	3,041	$44.1K	0.00%
Park Place Capital Corp	1,366	$20.0K	0.01%
Simplex Trading, LLC	89	$1.00K	0.00%
Quent Capital, LLC	65	$943	0.00%
Northwestern Mutual Wealth Management Co	49	$711	0.00%
Concord Wealth Partners	24	$348	0.00%
Farther Finance Advisors, LLC	15	$218	0.00%
Steward Financial Group LLC	19	$0	0.00%

Sold out (20)

Institutions that held Myriad Genetics Inc at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of MYGN in Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
PFM Health Sciences, LP	742,138	$14.2M
Eagle Asset Management Inc	351,164	$6.70M
Phocas Financial Corp.	130,705	$2.49M
Redhawk Wealth Advisors, Inc.	37,205	$710.0K
AlphaCrest Capital Management LLC	30,238	$577.0K
Ensign Peak Advisors, Inc	28,188	$538.0K
First Trust Advisors LP	26,760	$511.0K
Balyasny Asset Management LLC	26,245	$501.0K
Engineers Gate Manager LP	26,093	$498.0K
Zebra Capital Management LLC	13,672	$261.0K
Virginia Retirement Systems Et Al	11,400	$217.5K
Globeflex Capital L P	10,545	$201.0K
Point72 Hong Kong Ltd	3,337	$64.0K
Itau Unibanco Holding S.A.	2,405	$46.0K
Jackson, Grant Investment Advisers, Inc.	1,032	$20.0K
Dark Forest Capital Management LP	504	$10.0K
Plante Moran Financial Advisors, LLC	244	$5.00K
Investors Asset Management of Georgia Inc	202	$4.00K
Spire Wealth Management	190	$4.00K
De Burlo Group Inc	100	$1.91K

Not filed for Q4 2022 yet (3)

Institutions that held Myriad Genetics Inc at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding MYGN in Q3 2022 that haven't filed for Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Wipfli Financial Advisors LLC,	379	$7.00K
Surevest, LLC	206	$4.00K
American Portfolios Advisors	67	$1.28K